100 YEARS OF VITAMIN D: Historical aspects of vitamin D

Vitamin D has many physiological functions including upregulation of intestinal calcium and phosphate absorption, mobilization of bone resorption, renal reabsorption of calcium as well as actions on a variety of pleiotropic functions. It is believed that many of the hormonal effects of vitamin D involve a 1,25-dihydroxyvitamin D3-vitamin D receptor-mediated transcriptional mechanism involving binding to the cellular chromatin and regulating hundreds of genes in many tissues. This comprehensive historical review provides a unique perspective of the many steps of the discovery of vitamin D and its deficiency disease, rickets, stretching from 1650 until the present. The overview is divided into four distinct historical phases which cover the major developments in the field and in the process highlighting the: (a) first recognition of rickets or vitamin D deficiency; (b) discovery of the nutritional factor, vitamin D and its chemical structure; (c) elucidation of vitamin D metabolites including the hormonal form, 1,25-dihydroxyvitamin D3; (d) delineation of the vitamin D cellular machinery, functions and vitamin D-related diseases which focused on understanding the mechanism of action of vitamin D in its many target cells.

[1]  J. Pike,et al.  Genomic Mechanisms Governing Mineral Homeostasis and the Regulation and Maintenance of Vitamin D Metabolism , 2020, JBMR plus.

[2]  R. Bouillon,et al.  Vitamin D Binding Protein: A Historic Overview , 2020, Frontiers in Endocrinology.

[3]  Glenville Jones,et al.  Calcioic acid: In vivo detection and quantification of the terminal C24-oxidation product of 25-hydroxyvitamin D3 and related intermediates in serum of mice treated with 24,25-dihydroxyvitamin D3 , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  Glenville Jones The discovery and synthesis of the nutritional factor vitamin D. , 2018, International journal of paleopathology.

[5]  S. Mays The epidemiology of rickets in the 17th-19th centuries: Some contributions from documentary sources and their value to palaeopathologists. , 2017, International journal of paleopathology.

[6]  O. Mäkitie,et al.  Global Consensus Recommendations on Prevention and Management of Nutritional Rickets , 2016, Hormone Research in Paediatrics.

[7]  G. Kubica,et al.  Isolation and identification , 2015 .

[8]  O. Bijvoet,et al.  Rickets before the discovery of vitamin D. , 2014, BoneKEy reports.

[9]  Glenville Jones,et al.  Cytochrome P450-mediated metabolism of vitamin D , 2014, Journal of Lipid Research.

[10]  H. DeLuca,et al.  CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo , 2013, Proceedings of the National Academy of Sciences.

[11]  E. Schuetz,et al.  Interplay between vitamin D and the drug metabolizing enzyme CYP3A4 , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  R. Chesney Theobald Palm and His Remarkable Observation: How the Sunshine Vitamin Came to Be Recognized , 2012, Nutrients.

[13]  M. Konrad,et al.  Mutations in CYP24A1 and idiopathic infantile hypercalcemia. , 2011, The New England journal of medicine.

[14]  A. Norman,et al.  Vitamin D Sterol/VDR Conformational Dynamics and Nongenomic Actions , 2011 .

[15]  M. Haussler,et al.  Nuclear vitamin D receptor: Natural ligands, molecular structure-function, and transcriptional control of vital genes , 2011 .

[16]  H. DeLuca Historical Overview of Vitamin D , 2011 .

[17]  E. Mellanby An Experimental Investigation on Rickets , 2009 .

[18]  L. Swinburne Rickets and the Fairfax family receipt books. , 2006, Journal of the Royal Society of Medicine.

[19]  J. Pettifor Nutritional rickets: deficiency of vitamin D, calcium, or both? , 2004, The American journal of clinical nutrition.

[20]  Jeffrey B. Cheng,et al.  Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  F. Glorieux,et al.  Conventional and tissue‐specific inactivation of the 25‐hydroxyvitamin D‐1α‐hydroxylase (CYP27B1) , 2003, Journal of cellular biochemistry.

[22]  M. Tremblay,et al.  Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Inouye,et al.  Enzymatic studies on the key enzymes of vitamin D metabolism; 1 alpha-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24). , 2001, Biotechnology annual review.

[24]  S. Kato Vitamin D 1alpha-hydroxylase knockout mice as a hereditary rickets animal model. , 2001, Endocrinology.

[25]  F. Glorieux,et al.  Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. , 2000, Endocrinology.

[26]  D. Moras,et al.  The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. , 2000, Molecular cell.

[27]  K. Inouye,et al.  Metabolic studies using recombinant escherichia coli cells producing rat mitochondrial CYP24 CYP24 can convert 1alpha,25-dihydroxyvitamin D3 to calcitroic acid. , 1999, European journal of biochemistry.

[28]  H. DeLuca,et al.  Mechanisms and functions of vitamin D. , 2009, Nutrition reviews.

[29]  H. DeLuca,et al.  Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.

[30]  M. Demay,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Analysis of Vitamin D-Dependent Calcium-Binding Protein Messenger Ribonucleic Acid Expression in Mice , 2022 .

[31]  F. Glorieux,et al.  The 25‐Hydroxyvitamin D 1‐Alpha‐Hydroxylase Gene Maps to the Pseudovitamin D‐Deficiency Rickets (PDDR) Disease Locus , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  Tatsuya Yoshizawa,et al.  Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning , 1997, Nature Genetics.

[33]  A. Dusso,et al.  A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  S. Kato,et al.  25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. , 1997, Science.

[35]  R. Bouillon,et al.  Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.

[36]  K. Ray,et al.  Vitamin D binding protein: Genomic structure, functional domains, and mRNA expression in tissues , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[37]  Y. Ohyama,et al.  Isolation and characterization of a cytochrome P-450 from rat kidney mitochondria that catalyzes the 24-hydroxylation of 25-hydroxyvitamin D3. , 1991, The Journal of biological chemistry.

[38]  J. Shine,et al.  Cloning and expression of full-length cDNA encoding human vitamin D receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Haussler,et al.  Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. , 1987, Science.

[40]  M. Calverley Synthesis of mc 903, a biologically active vitamin D metabolite analogue , 1987 .

[41]  U. Liberman,et al.  A cellular defect in hereditary vitamin-D-dependent rickets type II: defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. , 1981, The New England journal of medicine.

[42]  H. DeLuca,et al.  Isolation and identification of 24-hydroxyvitamin D2 and 24,25-dihydroxyvitamin D2. , 1980, Archives of biochemistry and biophysics.

[43]  H. DeLuca,et al.  25-Hydroxyvitamin D3 26,23-lactone: a new in vivo metabolite of vitamin D. , 1979, Biochemistry.

[44]  H. DeLuca,et al.  Rickets with alopecia: an inborn error of vitamin D metabolism. , 1979, The Journal of pediatrics.

[45]  H. Tuppy,et al.  Hoppe-Seyler's zeitschrift fur physiologische chemie , 1977 .

[46]  H. Harter,et al.  Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. , 1977, The Journal of clinical investigation.

[47]  T. Martin,et al.  Metabolism of Vitamin D , 1976, Annals of clinical biochemistry.

[48]  D. Chick,et al.  Study of rickets in Vienna 1919-1922. , 1976, Medical History.

[49]  L. Cavalli-Sforza,et al.  Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Haussler,et al.  Specific binding of 1alpha,25-dihydroxycholecalciferol to nuclear components of chick intestine. , 1975, The Journal of biological chemistry.

[51]  H. DeLuca,et al.  25-Hydroxyvitamin D3-24-hydroxylase. Subcellular location and properties. , 1974, Biochemistry.

[52]  H. DeLuca,et al.  1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. , 1973, The Journal of biological chemistry.

[53]  Francis Glisson De Rachitide Sive Marbo Puerili, Qui Vulgo The Rickets Dicitur , 1973 .

[54]  H. DeLuca,et al.  The regulation of rat liver calciferol-25-hydroxylase. , 1973, The Journal of biological chemistry.

[55]  H. DeLuca,et al.  1α-Hydroxy Derivative of Vitamin D3: A Highly Potent Analog of 1α,25-Dihydroxyvitamin D3 , 1973, Science.

[56]  H. DeLuca,et al.  Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. , 1973, The New England journal of medicine.

[57]  H. DeLuca,et al.  25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties. , 1972, The Journal of biological chemistry.

[58]  H. DeLuca,et al.  Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. , 1972, Biochemistry.

[59]  H. DeLuca,et al.  The synthesis of 1α,25-dihydroxycholecalciferol -- A metabolically active form of vitamin D3 , 1972 .

[60]  H. DeLuca,et al.  Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. , 1971, Biochemistry.

[61]  H. DeLuca,et al.  25,26-dihydroxycholecalciferol, a metabolite of vitamin D3 with intestinal calcium transport activity. , 1970, Biochemistry.

[62]  D. Fraser,et al.  Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite , 1970, Nature.

[63]  H. DeLuca,et al.  Treatment of renal osteodystrophy with 25-hydroxycholecalciferol. , 1970, Archives of internal medicine.

[64]  H. DeLuca,et al.  21,25-dihydroxycholecalciferol. A metabolite of vitamin D3 preferentially active on bone. , 1970, Biochemistry.

[65]  M. Haussler,et al.  Evidence for the biologically active form of cholecalciferol in the intestine. , 1970, The Journal of biological chemistry.

[66]  M. Haussler,et al.  Chromosomal receptor for a vitamin D metabolite. , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[67]  H. DeLuca,et al.  25-hydroxyergocalciferol: a biologically active metabolite of vitamin D2. , 1969, Biochemical and biophysical research communications.

[68]  H. DeLuca,et al.  The synthesis of 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. , 1969, Biochemistry.

[69]  H. DeLuca,et al.  25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. , 1968, Biochemistry.

[70]  M. Haussler,et al.  The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. , 1968, The Journal of biological chemistry.

[71]  E. V. Mccollum The paths to the discovery of vitamins A and D. , 1967, The Journal of nutrition.

[72]  H. DeLuca,et al.  The synthesis of [1,2-3H]vitamin D3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat. , 1966, Biochemistry.

[73]  R. Mitchell Idiopathic hypercalcaemia of infants , 1958, Proceedings of the Nutrition Society.

[74]  W. Mozołowski Jędrzej Sniadecki (1768–1838) on the Cure of Rickets , 1939, Nature.

[75]  A. Windaus,et al.  Über das antirachitisch wirksame Bestrahlungsprodukt ans 7-Dehydro-cholesterin. , 1936 .

[76]  H. M. Bruce,et al.  The Distillation of Vitamin D. , 1930 .

[77]  H. Steenbock,et al.  FAT-SOLUBLE VITAMINS XXIII. THE INDUCTION OF GROWTH-PROMOTING AND CALCIFYING PROPERTIES IN FATS AND THEIR UNSAPONIFIABLE CONSTITUENTS BY EXPOSURE TO LIGHT , 1925 .

[78]  A. Hess,et al.  ANTIRACHITIC PROPERTIES IMPARTED TO INERT FLUIDS AND TO GREEN VEGETABLES BY ULTRA-VIOLET IRRADIATION , 1924 .

[79]  H. Steenbock,et al.  FAT-SOLUBLE VITAMINS XVII. THE INDUCTION OF GROWTH-PROMOTING AND CALCIFYING PROPERTIES IN A RATION BY EXPOSURE TO ULTRA-VIOLET LIGHT , 1924 .

[80]  E. V. Mccollum,et al.  STUDIES ON EXPERIMENTAL RICKETS XXI. AN EXPERIMENTAL DEMONSTRATION OF THE EXISTENCE OF A VITAMIN WHICH PROMOTES CALCIUM DEPOSITION , 1922 .

[81]  K. Huldschinsky Heilung von Rachitis durch künstliche Höhensonne , 1919 .

[82]  C. Funk The preparation from yeast and certain foodstuffs of the substance the deficiency of which in diet occasions polyneuritis in birds , 1912, The Journal of physiology.

[83]  F. G. Hopkins Feeding experiments illustrating the importance of accessory factors in normal dietaries , 1912, The Journal of physiology.

[84]  Justus Justus Liebig's Annalen der Chemie und Pharmacie , 1874 .